M&A - Dermata Therapeutics, Inc.

Form Type: 8-K

Filing Date: 2025-06-05

Corporate Action: Merger

Type: Update

Accession Number: 000164117225013823

Filing Summary: On June 3, 2025, Dermata Therapeutics, Inc. announced that its independent registered public accounting firm, Moss Adams LLP, has merged with Baker Tilly US, LLP, effective the same date. The appointment of Baker Tilly as the successor independent registered public accounting firm was approved by the audit committee of the Company's Board of Directors. Moss Adams provided audit reports on the Company's financial statements for the years ending December 31, 2024 and 2023, which did not contain any adverse opinions or disclaimers. There were no disagreements with Moss Adams regarding accounting principles or practices during the relevant periods. The Company consulted Moss Adams prior to the filing of this report, requesting a letter to the SEC regarding their agreement with the statements made.